NCT07472790 2026-03-16
A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1 Not yet recruiting
Clinical Trials
13 trialsNCT07465796 2026-03-12
CIPHER
Coherence Neuro Australia Pty Limited
Phase NA Not yet recruiting
NCT07464925 2026-03-11
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Tetragon Biosciences Ltd
Phase 1 Not yet recruiting
NCT07455045 2026-03-06
A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 1 Not yet recruiting
NCT07366892 2026-01-26
IMED-GLOW400
Leica Microsystems (Schweiz) AG
Not yet recruiting
NCT06357377 2026-01-14
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Neonc Technologies, Inc.
Phase 1 Not yet recruiting
NCT07164053 2025-11-20
IMED-MYVEO
Leica Microsystems (Schweiz) AG
Not yet recruiting
NCT07120984 2025-08-13
IMAGLIO
Philogen S.p.A.
Phase 2 Not yet recruiting
NCT06969352 2025-05-13
VICTORIA
Servier (Tianjin) Pharmaceutical Co. LTD.
Not yet recruiting
NCT06737146 2024-12-17
Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma
Suzhou Maximum Bio-tech Co., Ltd.
Phase 1 Not yet recruiting
NCT06329570 2024-03-26
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
NaviFUS Corporation
Phase 1/2 Not yet recruiting
NCT05958472 2023-07-24
Navigating the Clinical Research Process for Glioma
Power Life Sciences Inc.
Not yet recruiting
NCT05366062 2022-05-13
ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab
Epitopoietic Research Corporation
Phase 2 Not yet recruiting